Glycan, Herstellungsverfahren dafür und Verwendung davon sowie Antitumormittel
Anmelder: Peking University 🇨🇳
Details
- Veröffentlichungs-Nr.
- EP4741427
- Anmeldetag
- 5. September 2024
- Veröffentlichung
- 13. März 2025
- Rechtsraum
- EP
- IPC
- C08B37/00, A61K31/715
Abstract
A glycan, a preparation method therefor and a use thereof, and an anti-tumor drug, relating to the technical field of medicines. The glycan having a structure as shown in formula I has good anti-tumor activity and good safety. The results of the test example show that the glycan has a good proliferation inhibition effect on pancreatic cancer cells, has no cytotoxicity to the growth of hepatocytes, and shows better safety characteristics compared with a positive drug gemcitabine; in addition, the pancreatic cancer cells are sensitive to the glycan, thereby overcoming the problem that the pancreatic cancer cells have certain drug resistance to gemcitabine.
Anmelder
- Firma
- Peking University
- Land
- 🇨🇳 China
Peking University ist eine chinesische Eliteuniversität in Peking mit breiter Forschung und Patenten in zahlreichen Technologiefeldern, unter anderem Biotechnologie und Materialwissenschaften.
639 Patente in unserer Datenbank